🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

EP6 is live on YouTube and major platforms! Community oncologist Ben Fangman, MD, physician-scientist Kyle Concannon, MD, and patient Samantha M discuss local vs academic care. Ep 06: Academic Vs. Community Oncology | Cracking Cancer Podcast youtu.be/1d0F2AMjhhY?si… via YouTube

New findings from #AACR25 reveal that female survivors are significantly more likely to experience cancer-related fatigue and depression than male survivors. 🧠 Depression: 58% more likely 💤 Fatigue: 69% more likely 🏃‍♀️ Both linked to decreased recreational activity "It impacts

Patterns of progression in #EGFR exon 20 NSCLC on amivantamab Lung Cancer Journal. Lung/pleura most common sites of PD (29%), followed by bone (21 %), brain (15 %) lymph node (12 %). Intracranial only progression uncommon (11%); SRS on ami was safe. lungcancerjournal.info/article/S0169-…

Excited to share our article in the inaugural issue of the NEW MD Anderson Cancer Center ACE-QI journal, highlighting the impact of patient education. Grateful to Dr. Aurora Lucas, a young-onset lung cancer advocate, for bravely sharing her story. Read it here: openworks.mdanderson.org/cgi/viewconten…

Understanding cultural norms in cancer care is key. Aurora Lucas, an advocate living w EGFR #lungcancer, shares how she went from staying silent—out of fear of being disrespectful — to speaking up in this editorial with Dr @LungOncDoc. 👇 openworks.mdanderson.org/aceqi/vol1/iss… #LCSM

🤍Bianca, co-founder of Young Lung Cancer Initiative, has supported so many of us in the LC community. Her dad just passed away from EGFR NSCLC, only 2 yrs after losing her mom to lung cancer. If you feel moved to help, donations can be made here: gofundme.com/f/help-tony-di…

What a guy. I would’ve done anything to save you, Dad 💔🤍 m.sweeneymemorialfh.com/obituaries/eve… #lcsm #lungcancer #egfr

Using human genetics to understand the epidemiological association between neuroticism and lung cancer “This study reveals a genetic link between neuroticism and LC.” tlcr.amegroups.org/article/view/9…

Young people get #cancer. Amy was just 20 when she was diagnosed w stage 4 #lungcancer. Her story & others show why we must act now. Amy’s what’s inspired Janclark to co-found our charity. Thanks The Sun for covering this important issue: thesun.co.uk/health/3502801… 🩵 #LCSM

Thank you Samantha M for opening up about the emotional toxicity of false cure claims!

Three years ago today, I had absolutely no idea what had just hit me. Stage 4 ALK Positive Lung Cancer at just 35 years of age? What on earth was that? Even now, I’m not sure I have better answers. I’ve learned to navigate this so-called “new normal,” but let’s be honest—it’s

Brief report JTO & JTO CRR on pregnancy and healthy baby on lorlatinib for #ALK NSCLC. Lorlatinib held weeks 4-20, then resumed. At 20m post-partum, ongoing PR & no congenital abnormalities in baby despite PK showing placental transfer of lorlatinib. jto.org/article/S1556-…

I SAID WHAT I SAID. #lungcancer #invisibleillness

🚨 New insights in #RETpositive #LungCancer: RET+ NSCLC often express MET & TROP2, moderately HER3 & EGFR, and rarely HER2. ➡️ Multiple membrane targets may co-exist 🧬 Dynamic changes post-treatment — fresh biopsy recommended 💡 Supports ADC & bispecific antibody trials

🤍🤍

🆕 #ASCO25 🆙 ☑️Developmental Tx, Oral 🔥BL-B01D1: EGFR x HER3 bispecific ADC in pts with NSCLC with driver genomic alterations 🎙️ Dr. Yunpeng Yang 🎯ORR: EGFR ex20ins 69.2%, HER2 52.9%, ALK/ROS1/RET 34.8%, KRAS/BRAF/MET 40.0% OncoAlert ASCO LARVOL meetings.asco.org/2025-asco-annu…

So excited so bring #HearHer to ASCO! As one of the largest cancer research conferences we are ready. Lung cancer does effect women- let’s talk about it. If you see an #FlorezLab member or Narjust Florez, MD, FASCO get your pin! We are excited to be here and see you all soon!

Leah Leah Phillips representing Young Lung Cancer Initiative at #ASCO25 🤍

#HearHer is at #ASCO25 - n=200 ONLY Stop me ✋ or #FlorezLab team for yours Because lung cancer is a disease of WOMEN Young Lung Cancer Initiative OncoAlert Oncology Brothers ASCO

Congratulations to Taiho Oncology for REZ1 impressive data. No surprise for zipalertinib patients and care partners in the Exon 20 Group! Glad to see the CNS confirmation! taihooncology.com/us/news/taiho-…